Allink Biotherapeutics

Allink Biotherapeutics is a clinical-stage biotechnology company developing next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics for oncology and immunology diseases. The company focuses on creating First-in-Class (FIC) and Best-in-Class (BIC) therapeutics to address critical unmet medical needs globally. Their innovative platforms are driving the development of a diverse pipeline of promising drug candidates.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $42M

Date: 28-Nov-2024

Investors: Lanchi Ventures, Yuanbio Venture Capital, Legend Capital, C&D Emerging Industry Equity Investment, Gaorong Ventures, Med-Fine Capital

Markets: Biotechnology, Oncology, Immunology, Drug Discovery

HQ: Shanghai, China

Founded: 2023

Website: https://www.allinkbio.com/

LinkedIn: https://www.linkedin.com/company/allinkbio

Twitter:

Instagram: